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ABSTRACT 
Introduction: There is a paucity of data evaluating antibiotic use in anterior skull base surgery 
(ASBS). The goal of this study was to determine antibiotic prescribing patterns and factors that 
influence antibiotic use in ASBS. 
 
Methods: An online-based survey was distributed to the membership of the North American Skull 
Base Society in 2018. Outcomes included practitioner preference regarding intra- and postoperative 
antibiotic use, practice location and environment, surgeon experience, and patient factors 
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Results: There was a total of 208 respondents (25.6% response rate) of which 182 (87.5%) 
performed ASBS.  60.4% were in academic institutions. Respondents were neurosurgeons (59.3%) or 
otolaryngologists (40.7%), and 75.3% were fellowship-trained in ASBS.  Most surgeons (95.0%) gave 
intraoperative antibiotics.  Academic surgeons were 4 times more likely to prescribe intraoperative 
antibiotics than private practitioners (OR 3.98 [95% CI 1.53-10.36], p=0.005). Among surgeons who 
did not routinely prescribe intraoperative antibiotics, regression analysis indicated that the presence 
of actively infected sinuses, transplantation, diabetes, HIV/AIDS, and pulmonary disease influenced 
decision-making (p<0.03).  Postoperative antibiotics were prescribed by 73.6% of respondents.  
European surgeons were 3 times less likely to prescribe postoperative antibiotics (OR 0.34 [95% CI 
0.15-0.80], p=0.01).  Regression modeling indicated that HIV/AIDS, cystic fibrosis, diabetes, 
transplantation, and pulmonary disease, as well as the use of absorbable packing influenced the 
decision to use postoperative antibiotics (p<0.003).   
 
Conclusion: This study demonstrates the significant variation in intra- and postoperative antibiotic 
use among surgeons performing ASBS.  Prospective randomized studies are necessary to establish 




Skull base surgery (SBS) can be classified as clean or clean-contaminated depending on whether 
sinonasal mucosa is violated.  In many cases, there is a direct connection between the sinonasal 
mucosa and intracranial space.  Furthermore, endoscopic cases involve transnasal passage of 
instruments and graft materials. These two factors create a theoretical risk for contamination of the 
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endoscopic expanded endonasal approaches for SBS showed an overall postoperative rate of 
meningitis of 1.8% with higher rates in cases of postoperative cerebrospinal fluid (CSF) leak.1 Given 
the severe consequences of an intracranial infection, perioperative antibiotics are routinely used in 
anterior skull base surgery (ASBS).   
 
To date, there have been no randomized controlled trials evaluating the use of prophylactic 
antibiotics for clean-contaminated ASBS.  A recent evidence-based review by Patel et al. 
recommended intra- and postoperative antibiotic use for less than 24 hours.2 The exception being 
cases where the use of nasal packing or splints is anticipated to exceed 48 hours, though there is a 
paucity of evidence for this recommendation.  The theoretical benefits of antibiotic use in ASBS 
include a reduction in infection risk by sterilizing CSF that is seeded by sinonasal flora during surgical 
extirpation of the lesion.  However, the prophylactic use of antibiotics should be weighed against the 
costs and potential side effects, including allergic reactions, Clostridium difficile enterocolitis, and 
spread of antimicrobial resistance.3   
 
Given the lack of high-level evidence supporting the use of perioperative antibiotics in ASBS, we 
sought to survey the members of the North American Skull Base Society (NASBS) to determine 
current practice patterns pertaining to perioperative antibiotic use and to identify factors that 
influence the use of antibiotics.   
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A 22-item online-based survey was designed using SurveyMonkey (San Mateo, CA). This study was 
electronically distributed to the general NASBS membership. Three e-mail notifications were sent 
over a period of eight weeks. The survey remained open online for a period of 4 weeks after the final 
notification and participation was voluntary. Responses were recorded anonymously, and no 
identifying information was collected. 
 
Demographic characteristics of the respondents were collected, including type of clinical practice 
(full-time academic, private practice with academic affiliation, independent private practice, 
government facility), geographic location of the practice, duration of practice in years, neurosurgical 
or otolaryngology training, and completion of a fellowship.  Practice volume was assessed by 
number of ASBS cases performed per year.  Intraoperative and postoperative antibiotic practice 
patterns were assessed.  Frequency of antibiotic use in each of these categories was stratified as 
“Always (100% of the time)”, “Often (>70% of the time)”, “Sometimes (30-70% of the time)”, or 
“Infrequent (<30% of the time)”.  Respondents were given the opportunity to select one or more 
reasons as to why they prescribed perioperative antibiotics.  The impact of patient comorbidities on 
antibiotic use was also assessed.  The type and duration of antibiotic used, placement of a lumbar 
drain, use of intranasal packing, and information on methods used to diagnose a postoperative 
infection was obtained.  
 
Only complete survey responses were included in the analysis.  Percentage response rates were 
calculated for each item based on the number of respondents for that specific item.  Responses 
were operationalized and entered into Excel 2016 (Microsoft, Redmond, WA) and then transferred 
to SPSS Statistics v21.0 (IBM, Armonk, NY) for statistical analysis.  Associations between variables 
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Any variable that differed between those using and those not using antibiotics with a p-value ≤0.20 
on bivariate analysis was considered a potential independent variable and was entered a 
multivariate logistic regression model. Significant differences were identified at a conventional 0.05 





Of the 813 NASBS members who received the survey, 208 respondents completed the survey for a 
response rate of 25.6%.  Not every question was applicable to every respondent – for example, 
those who did not prescribe postoperative antibiotics were not then asked about reasons for 
prescribing postoperative antibiotics.  Consequently, the response rate for each survey question 
ranged from 64.4 to 100%.  
 
Of the 208 respondents, 182 perform ASBS (Table 1).  Of these 182 respondents, the majority 
(n=130, 71%) were in a full-time academic or government-funded position.  Twenty-nine percent 
(n=52) were in private practice, of whom 79% (n=41) were academically affiliated and 21% (n=11) 
were in independent practice.  Over half of the respondents were neurosurgeons (n=108, 59.3%) 
and the remainder (n=74, 40.7%) were otolaryngologists.  Most respondents had undergone 
fellowship training in SBS (n=137, 75.3%).  Geographic practice location was provided by 178 
respondents.  Over half (61.5%) were from North America, 15.2% from Europe, 12.9% were from 
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There was a wide range of experience among respondents (Table 1).  Forty-two respondents (23.1%) 
had over 20 years of experience, but nearly one-third (n=57, 31.3%) had been in practice for less 
than 5 years.  Many respondents (n=126, 69.2%) perform open and endoscopic SBS, whereas a 
smaller percentage perform only endoscopic (n=37, 20.3%) or only open SBS (n=19, 10.4%). 
 
Intraoperative antibiotic use patterns 
Most respondents who performed ASBS used intraoperative antibiotics (n=173, 95.1%) with 85.0% 
(n=155) indicating that they gave intraoperative antibiotics 100% of the time (Table 2).  In a 
multivariable logistic regression model controlling for surgeon volume, years of experience, and type 
of SBS (open, endoscopic, or both), being a full-time academic surgeon (including those in 
government practice) was associated with prescribing more intraoperative antibiotics (OR 6.67 [95% 
CI 1.34-33.12], p=0.02).  Given that most prescribers of intraoperative antibiotics prescribed these 
“100% of the time”, we restratified intraoperative antibiotic use into “never”, “sometimes (<100%)” 
and “always (100% of the time)”.  In a multivariate cumulative logit model controlling for surgeon 
volume, years of experience, and type of skull base surgery, academic surgeons were found to 
prescribe intraoperative antibiotics 4 times more frequently than private practitioners (OR 3.98 [95% 
CI 1.53-10.36], p=0.005).  The most commonly used intraoperative antibiotics were 1st-2nd 
generation cephalosporins (n=96, 55.5%) and 3rd-5th generation cephalosporins (n=75, 43.4%) (Table 
2).    
 
Of the 173 respondents who gave intraoperative antibiotics, the most common reason was to 
reduce the risk of postoperative infection (n=157, 90.8%) (Table 3).  By using logistic regression 
modelling, we analyzed factors associated with use of intraoperative antibiotics less than 100% of 
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give intraoperative antibiotics.  Surgeons who reported “actively infected sinuses” as one of the 
reasons to prescribe intraoperative antibiotics were less likely to prescribe intraoperative antibiotics 
100% of the time (OR 0.3 [95% CI 0.1-0.8], p=0.027).  Most respondents (n=148, 85.5%) stated that 
they would not change their intraoperative antibiotic prescribing pattern based on patient 
comorbidities (Table 4).  Of the minority who personalize intraoperative antibiotic use based on 
patient comorbidities (n=25, 14.5%), a history of transplantation, diabetes, human 
immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS), and pulmonary disease 
were each independently associated with a reduced likelihood of prescribing intraoperative 
antibiotics 100% of the time (OR 1.0 for each factor, p<0.02) (Table 4).  This suggests that among 
surgeons who did not reflexively prescribe intraoperative antibiotics, these comorbidities were the 
most influential factors in informing antibiotic use. 
 
Postoperative antibiotic use patterns 
Most respondents (n=134, 73.6%) gave postoperative antibiotics after ASBS (Table 1).  Over half 
(n=112, 62%) gave postoperative antibiotics for every case, whereas 26% (n=48) never gave 
postoperative antibiotics. A small minority of respondents (n=22, 11%) sometimes gave antibiotics 
postoperatively (Table 2).  By stratifying postoperative antibiotic use as “always (100% of the time)”, 
“sometimes (<100%)”, and “never”, we built a multivariable cumulative logit model that controlled 
for surgeon volume, years of experience, and type of SBS. Our model indicated that European 
surgeons were nearly 3 times more likely than others to never prescribe postoperative antibiotics 
(OR 0.34 [95% CI 0.15-0.80], p=0.01).  
Postoperative antibiotics were generally given for 24 hours (n=41, 30.6%), 24-72 hours (n=40, 
29.9%), or 1 week (n=36, 26.9%).  They were less frequently given for 1-2 weeks (n=16, 11.9%).  The 
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or 3rd-5th generation cephalosporins (n=59, 44.0%) (Table 2).  Postoperative antibiotics were most 
commonly given to prevent postoperative infection (82.1%), to reduce the perceived infection risk of 
non-absorbable packing (n=51, 38.1%), and secondary to concern for a potential CSF leak (n=31, 
23.1%).  Surgeons who reported “use of absorbable packing” (OR 0.2 [95% CI 0.1-0.6], p=0.003) or 
“that’s how I was taught” (OR 0.3 [95% CI 0.1-0.8], p=0.027) as a reason for prescribing 
postoperative antibiotics were less likely to prescribe postoperative antibiotics 100% of the time, 
suggesting that this cohort may be more discriminating in their decision to use antibiotics (Table 3).     
Surgeons were also asked how often they give culture-directed postoperative antibiotics.  Less than 
one-third of respondents (n=33, 24.6%) used culture-directed postoperative antibiotics on every 
occasion.  The majority (n=41, 30.6%) of those who used culture-directed postoperative antibiotics, 
reported that they used cultures to inform the prescription less than 30% of the time.  Of the 
respondents who give postoperative antibiotics, nearly three-quarters (n=100, 74.6%) reported that 
their decision was not influenced by patient comorbidities.  Of the 34 respondents (25.4%) who 
reported that their decision to prescribe postoperative antibiotics was influenced by patient 
comorbidities, HIV/AIDS, cystic fibrosis, diabetes, history of transplant, and pulmonary disease all 
reduced the likelihood that the surgeon would reflexively prescribe postoperative antibiotics for 
ASBS (Table 4).  These factors directly influenced decision-making, with history of transplant having 
the most effect on the decision to use postoperative antibiotics among surgeons who do not 
routinely prescribe them for every case (OR 0.1 [95% CI 0.04-0.4], p<0.0001).   
Surgeons were asked how they diagnosed postoperative infection.  Most respondents used systemic 
symptoms and signs, such as fever and increased white blood cell count (n=124, 92.5%).  
Visualization of purulence on postoperative endoscopic examination (n=93, 69.4%) and patient 









Anterior skull base surgery approaches often involve passage through the microbe-rich nasal cavity 
to access the sterile intracranial space.  The sinonasal cavities are known to be reservoirs of several 
bacterial species including Staphylococcus aureus, Haemophilus influenzae, Moraxella catarrhalis, 
and Streptococcus pneumoniae.4  Prophylactic antibiotics are commonly used in this setting to 
prevent a postoperative infection.  The use of prophylactic antibiotics in surgery is commonly 
dictated by the nature of the procedure and patient characteristics.  For example, in neurosurgery, 
the use of prophylactic antibiotics is supported by a prospective study of 4,578 craniotomies by 
Korinek et al.5 The initial cohort of cases were not prescribed penicillin-based prophylaxis for 
scheduled, clean craniotomies of short duration whereas emergent, clean-contaminated or longer 
duration cases did receive antibiotic prophylaxis.  The subsequent cohort of cases received antibiotic 
prophylaxis regardless of craniotomy characteristics.  Antibiotic prophylaxis reduced postoperative 
infection rate from 9.7% to 5.8% across the study population primarily due to significant reductions 
in infection rates among low risk patients from 10.0% to 4.6%.   
Despite the minimally invasive nature of endoscopic ASBS, communication between the sinonasal 
and intracranial cavities may represent a higher risk of postoperative infection compared to open 
skull base procedures.  Furthermore, institutional guidelines on antibiotic prophylaxis often vary 
depending upon whether the dura is violated during ASBS.  Given the expanding indications of 
endoscopic ASBS, evidence-based guidelines of perioperative antibiotic management should be 
established.  The recent American Rhinologic Society (ARS) international consensus statement on 
endoscopic SBS does not make a recommendation for or against perioperative antibiotic use, 
deferring to surgeon discretion.6 We sought to determine the practice patterns of anterior skull base 
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Web-based physician-directed surveys often have response rates below 20%.7,8 Our survey response 
rate was 25.6%, which is comparable to the response rates in prior survey studies.9-14 The majority of 
our respondents worked in full-time academic positions (60.4%) and had undergone fellowship 
training (75.3%), which speaks to the nature of ASBS cases that usually require high-level tertiary 
multi-specialty care.  Though nearly a third of respondents (31.3%) had been in practice for less than 
5 years, 23.1% had over 20 years of experience.  Thus, the responses detailed in this study likely 
represent the opinions of a highly-trained and, in many instances, experienced cohort. 
Neurosurgeons represented 59.3% and otolaryngologists 40.7% of the study cohort.  Our 
respondents were from many geographic locations, including North America (61.5%), Europe 
(15.2%), and Asia (8.4%). The diversity of geographic location and specialty background improves the 
generalizability of our results.   
 
Most of our survey respondents (95.1%) gave intraoperative antibiotics for ASBS cases and 85.0% 
gave antibiotics for every case.  Academic surgeons were four times more likely than private 
practitioners to give intraoperative prophylactic antibiotics. This could reflect the increased 
complexity of cases presenting to a tertiary referral academic center.    The inherent risk of CSF leak, 
which is a known risk factor for postoperative infection in SBS, is higher in cases of greater 
complexity where a larger skull base defect is created.6,15-18 In a retrospective chart review of 1,000 
patients who underwent endoscopic SBS, both CSF leak and high level of case complexity, were 
associated with a higher risk of postoperative infection.15  Unsurprisingly, the desire to reduce the 
risk of postoperative infection was the driving factor to prescribe intraoperative antibiotics in 91% of 
respondents.  Among surgeons who did not routinely prescribe intraoperative antibiotics for every 
ASBS case, the presence of actively infected sinuses or patient comorbidities including 
transplantation, diabetes, HIV/AIDS, and pulmonary disease influenced decision-making on whether 
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Interestingly, we did not find a difference in antibiotic usage between those performing endoscopic 
approaches versus open approaches.  The incidence of postoperative meningitis in these two groups 
has not been shown to vary greatly with rates ranging from <1-14% for endoscopic endonasal SBS18-
22 versus 1.8-11% for open craniofacial SBS.16,22,23. 
 
Of the participants who gave intraoperative antibiotics, the majority used a 1st or 2nd generation 
cephalosporin (55.5%) or a 3rd, 4th, or 5th generation cephalosporin (43.4%).  This is similar to findings 
in a survey of endoscopic skull base surgeons among the membership of the ARS, in which many 
respondents used 1st generation  (41.4%) or 3rd generation cephalosporins (35.7%).11  First-
generation cephalosporins, namely cefazolin, have a good safety profile, a favorable duration of 
action, and adequate coverage of organisms commonly involved in surgical site infections, including 
Staphylococcus species.24,25  3rd, 4th, and 5th generation cephalosporins may be preferred for their 
improved blood-brain barrier penetration.  These newer medications achieve higher concentrations 
in the CSF that are sufficient to inhibit Staphylococcus and a wide spectrum of gram-positive and 
gram-negative bacteria.26   
 
The use of prophylactic antibiotic coverage for ASBS was first addressed by Carrau et al. in 1991 who 
recommended coverage of gram-positive and gram-negative bacteria for at least 48 hours following 
surgery.27 They noted that ideal antibiotic prophylaxis would include good CSF penetration, single 
agent therapy, absence of associated morbidity, and convenient dosing schedule.27  To date, there 
are no randomized controlled trials evaluating the appropriate choice, number, and duration of 
antibiotics in ASBS.  Indeed, a prior survey of the membership of the International Society of 
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evidence guiding perioperative antibiotic use in endoscopic pituitary surgery.28 Studies have 
suggested that there is a potential benefit of broad-spectrum antibiotic coverage in ASBS.  A 
prospective study of 211 patients undergoing open SBS compared patients who received an 
antibiotic regimen of ceftazidime, metronidazole, and vancomycin of varying duration to those who 
received non-standardized antibiotic prophylaxis.16  Those who received the standardized antibiotic 
regimen were 2.5 times less likely to develop an infectious complication.16   
 
Although the use of broad-spectrum prophylaxis intraoperatively appears to be beneficial, optimal 
postoperative antibiotic prophylaxis has yet to be established.  Postoperative antibiotic prophylaxis 
was used by 73.6% of survey respondents, and 62% always gave postoperative antibiotics.  
Cephalosporins were the preferred agents.  Postoperative antibiotics were given for 24 hours by 
approximately one-third of respondents or 24 to 72 hours by nearly 30% of respondents.  Several 
studies have suggested that a short course of postoperative antibiotics is adequate for prophylaxis in 
ASBS.18,19,29-31 One prior study found that the use of a single agent covering gram-positive organisms 
for 24 to 48 hours was adequate prophylaxis for endoscopic endonasal ASBS.  In this study,  none of 
the 90 patients who underwent ASBS developed postoperative meningitis.30 Another study 
recommended that two doses of cefuroxime is adequate for transsphenoidal pituitary surgery.29 In a 
retrospective analysis of 145 patients who underwent endoscopic endonasal transsphenoidal 
surgery who received an intraoperative and single postoperative dose of cefazolin, none developed 
meningitis.31 Based on these studies, an evidence-based review recommended less than 24 hours of 
postoperative antibiotic prophylaxis for clean-contaminated ASBS, except in cases where nasal 
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Interestingly, we found that European surgeons were three times less likely than surgeons in other 
geographic regions to give postoperative prophylaxis, which suggests that there are geographic 
influences on antibiotic practice patterns.  An Italian study of 2,039 patients who underwent ASBS 
followed an antibiotic protocol that did not use any postoperative antibiotics with a postoperative 
meningitis rate of only 0.69%.18 The reasons for these geographic disparities in postoperative 
antibiotic use have not been evaluated.  Potential explanations may be related to the centralization 
of SBS in Europe to select large volume academic centers.  Adherence to strict antibiotic stewardship 
guidelines could be more common in these centers.  Similarly, the nationalized healthcare systems in 
many Western European countries prioritize cost containment and in the United Kingdom, for 
example, bodies such as the National Institute for Health and Care Excellence (NICE) provide 
evidence-based guidance which strongly recommend against treatments for which there is no strong 
evidence base.     
 
In our study, the most common reason cited for use of postoperative antibiotics was to prevent 
postoperative infection (82.1%), and the second most common reason was for prophylaxis in the 
setting of non-absorbable packing (38.1%).  This is similar to findings in a survey of the ARS, in which 
39.1% of respondents prescribed a seven-day course of oral antibiotics in the setting of nasal 
packing.11  This is a much lower percentage than reported by the prior survey of the NASBS, where 
88.5% of respondents who used non-absorbable packing gave postoperative antibiotics.12  
Antibiotics are commonly prescribed in the setting of non-absorbable packing for fear of toxic shock 
syndrome despite its extremely rare incidence.  There is limited data supporting postoperative 
antibiotic use in the setting of nasal packing following ASBS.32 Despite the lack of evidence, one-
quarter (25.4%) of those surveyed modified their use of postoperative antibiotics depending on 
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The limitations of this study include those that are inherent to survey studies.  Web-based surveys 
often have response rates below 20%.7,8  Though the response rate of approximately 25% in the 
current study is marginally better, this rate is still significantly lower than that achieved through 
other modes of survey distribution, some of which use incentives, which increase study costs.8 The 
relatively low response rate achieved in the current study may lead to non-response bias.  The 
sample population represents a self-selected group of NASBS members who chose to participate in 
the distributed survey.  Consequently, the generalizability of results across the 75% of NASBS 
members who did not respond to this survey, and to the wider population of surgeons cannot be 
assured.  To illustrate, 60.4% of respondents were in an academic practice and may manage higher 
complexity cases in environments that tend to have standardized perioperative workflows biasing 
responses in favor of antibiotic use.  This may underlie the observed association between practicing 
in an academic environment and increased intraoperative antibiotic use compared to non-academic 
surgeons.  Recall bias of case numbers and other details by respondents is another possible 
limitation.  Questions were asked in a multiple-choice format. For example, respondents were given 
different options as to why they prescribed intraoperative or postoperative antibiotics.  Responses 
other than those designated by the survey authors were not permitted, potentially introducing a 
selection bias.  Permitting respondents to free text responses may have reduced—but would not 
have ameliorated—this bias.  The implications are that there may be factors which influence 
antibiotic use that were not identified in this study.  In addition, most respondents were from North 
America, likely biasing the reported practices in this study towards those implemented in North 
America where antibiotic overuse is widely acknowledged.  Reported responses in this study 
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Despite the lack of high-quality evidence supporting the use and duration of perioperative 
antibiotics in ASBS, our survey study demonstrates that a large proportion of our respondents give 
intraoperative and postoperative antibiotic prophylaxis. Several patient factors, including comorbid 
conditions, influence surgeon decision-making as it pertains to prescribing intra- and postoperative 
antibiotics.  Practice setting and geographic location may also play a role in prescribing practices. A 
prospective randomized controlled trial evaluating perioperative antibiotic use in ASBS is necessary 
to develop high-quality evidence-based practice guidelines.  
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# of Skull Base Cases 
     0-10 
     11-25 
     25-50 
     51-100 
     100+ 
Skull Base as % of Practice 
     <25% 
     25-50% 
     51-75% 
     76-100% 
Type of Operation 
     Endoscopic 
     Open 
     Both 
Work Setting 
     Academic/Gov. 
     Private practice 
Geographic Location 
     North America 
     Europe 
     South and Central America 
     Africa 
     Australia and Asia     
Primary Field 
     Otolaryngology 
     Neurosurgery 
Fellowship Trained 
     Yes 
     No 
Years in Practice 
     0-5 
     5-10 
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a) % may not add to 100% due to rounding in column 3. 
 
Table 1: Respondent demographic and practice characteristics. 
 
How often do you 






0% of the time 9 5% 48 26% 
1-29% of the time 4 2% 4 2% 
30-69% of the time 5 3% 8 4% 
70-99% of the time 9 5% 10 5% 
100% of the time 155 85% 112 62% 


















75 43% 59 44% 
Penicillins (e.g. 
oxacillin) 





8 5% 9 7% 
Aminoglycosides (e.g. 
gentamicin) 
9 5% 6 5% 
Quinolones (e.g. 
ciprofloxacin) 
3 2% 6 5% 
Macrolides (e.g. 
erythromycin) 
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Table 2.  Frequency and types of antibiotics prescribed.  Respondents were given answer choices of 





antibiotic (n) % 
Postoperative 
antibiotic (n) % p-value OR 
Intraoperative 
antibiotics 




47 27%   0.027 0.3 (0.1,0.8) 
Active CSF 
leak 
49 28%   0.298  
To reduce risk 
of bacteremia 
45 26%   0.346  








41 24%   0.060  
Use of lumbar 
drain 
16 9%   0.540  
That’s how I 
was taught 
28 16%   0.216  
Lincosamides (e.g. 
clindamycin) 
15 9% 6 5% 
Nitroimidazole (e.g. 
metronidazole) 
15 9% 13 10% 
Folate inhibitors (e.g. 
trimethoprim-
sulfamethoxazole) 
1 1% 4 3% 
Glycopeptides (e.g. 
vancomycin) 
43 25% 31 23% 
Tetracyclines (e.g. 
doxycycline) 
0 0% 2 1% 
Carbapenems (e.g. 
meropenem) 












  110 82% 0.113  
Concern for 
active CSF leak 













  24 18% 0.884  
Use of lumbar 
drain 








  51 38% 0.176  
That’s how I 
was taught 
  23 17% 0.027 0.3 (0.1,0.8) 
 
Table 3.  Reasons for prescribing intraoperative and postoperative antibiotics.  Respondents were 
given answer choices of which they could select multiple answers.  Odds ratio and p-value are from 
logistic regression modelling frequency among prescribers of antibiotics.  Model is predicting 










This article is protected by copyright. All rights reserved. 
 






% p-value OR Post-
operative 
antibiotic 
% p-value OR 




148 86% <0.0001 8.7 (3.0, 25.0) 100 75% 0.0012 4.9 (1.9, 12.8) 
HIV/AIDs 14 8% 0.0003 0.1 (0.03, 0.4) 16 12% 0.0212 0.3 (0.1, 0.8) 
Cystic fibrosis 9 5% 0.2493  15 11% 0.0138 0.2 (0.1, 0.7) 
Diabetes 17 10% 0.0001 0.1 (0.04, 0.3) 25 19% 0.0243 0.3 (0.1, 0.9) 
Transplant patient 19 11% <0.0001 0.1 (0.03, 0.3) 24 18% <0.000
1 
0.1 (0.04, 0.4) 
Cardiac disease 7 4% 0.1316  9 7% 0.1712 0.4 (0.1, 1.6) 
Pulmonary disease 7 4% 0.0126 0.1 (0.03, 0.6) 11 8% 0.0125 0.2 (0.1, 0.7) 
Table 4.  Factors that potentially influence prescribing decision.  Respondents were given answer 
choices of which they could select multiple answers.  Odds ratio and p-value are from logistic 
regression modelling frequency among prescribers of antibiotics.  Model is predicting probability 
that the surgeon prescribes antibiotics 100% of the time.  Abbreviations: HIV/AIDS, human 
immunodeficiency virus/acquired immune deficiency syndrome. 
